tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)
:0874
Holding HK:0874?
Track your performance easily

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Stock Price & Analysis

0 Followers

0874 Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

3.73%93.58%
Insiders
― Other Institutional Investors
93.58% Public Companies and
Individual Investors

0874 FAQ

What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price range in the past 12 months?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H lowest stock price was HK$16.62 and its highest was HK$24.20 in the past 12 months.
    What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap?
    Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap is $44.35B.
      When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date?
      Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date is Mar 17, 2025 which is in 49 days.
        How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s earnings last quarter?
        Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H released its earnings results on Oct 25, 2024. The company reported HK$0.396 earnings per share for the quarter, missing the consensus estimate of HK$0.481 by -HK$0.086.
          Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H overvalued?
          According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pay dividends?
            Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pays a Annually dividend of HK$0.442 which represents an annual dividend yield of 7.26%. See more information on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividends here
              What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate?
              Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate is 0.32.
                How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H have?
                Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has 219,900,000 shares outstanding.
                  What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price movement after its last earnings report?
                  Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H reported an EPS of HK$0.396 in its last earnings report, missing expectations of HK$0.481. Following the earnings report the stock price went up 0.21%.
                    Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?
                    Currently, no hedge funds are holding shares in HK:0874
                    ---

                    Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score

                    Company Description

                    Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H

                    Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its operations are divided into three main segments: pharmaceutical manufacturing, pharmaceutical distribution & retail, and health products. The greater portion of its revenue comes from its pharmaceutical activities in patent medicine, raw materials, distribution, and retail. The rest of its revenues come from its beverage, food, cosmetics, and health products. The company's primary market is China.
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Sino Biopharmaceutical
                    CSPC Pharmaceutical Group
                    Livzon Pharmaceutical Group
                    Shenzhou International Group Holdings
                    China Resources Pharmaceutical Group Ltd.
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis